IDXX RSI Chart
Last 7 days
4.1%
Last 30 days
-5.3%
Last 90 days
-15.1%
Trailing 12 Months
1.6%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 3.7B | 0 | 0 | 0 |
2023 | 3.4B | 3.5B | 3.6B | 3.7B |
2022 | 3.3B | 3.3B | 3.3B | 3.4B |
2021 | 2.9B | 3.0B | 3.1B | 3.2B |
2020 | 2.5B | 2.5B | 2.6B | 2.7B |
2019 | 2.3B | 2.3B | 2.4B | 2.4B |
2018 | 2.0B | 2.1B | 2.2B | 2.2B |
2017 | 1.8B | 1.9B | 1.9B | 2.0B |
2016 | 1.6B | 1.7B | 1.7B | 1.8B |
2015 | 1.5B | 1.5B | 1.6B | 1.6B |
2014 | 1.4B | 1.4B | 1.5B | 1.5B |
2013 | 1.3B | 1.3B | 1.3B | 1.4B |
2012 | 1.2B | 1.3B | 1.3B | 1.3B |
2011 | 1.1B | 1.2B | 1.2B | 1.2B |
2010 | 1.1B | 1.1B | 1.1B | 1.1B |
2009 | 0 | 1.0B | 1.0B | 1.0B |
2008 | 0 | 0 | 0 | 1.0B |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index
Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.
Returns of $10,000 invested in:
Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022
Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 06, 2024 | polewaczyk james f | acquired | 3,423,550 | 422 | 8,104 | executive vice president |
Mar 06, 2024 | polewaczyk james f | sold | -4,525,600 | 558 | -8,104 | executive vice president |
Mar 05, 2024 | vandebroek sophie v. | sold | -790,427 | 562 | -1,404 | - |
Mar 05, 2024 | vandebroek sophie v. | acquired | 345,089 | 245 | 1,404 | - |
Feb 29, 2024 | mazelsky jonathan jay | gifted | - | - | -550 | president and ceo |
Feb 21, 2024 | mazelsky jonathan jay | acquired | 99,952 | 206 | 483 | president and ceo |
Feb 16, 2024 | underberg sharon e. | acquired | 99,952 | 206 | 483 | evp, gc & corporate secretary |
Feb 15, 2024 | mckeon brian p | acquired | 99,952 | 206 | 483 | evp, cfo and treasurer |
Feb 14, 2024 | underberg sharon e. | acquired | - | - | 1,186 | evp, gc & corporate secretary |
Feb 14, 2024 | schreck michael | sold (taxes) | -65,585 | 560 | -117 | executive vice president |
Which funds bought or sold IDXX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 07, 2024 | Atomi Financial Group, Inc. | added | 3.41 | 2,024 | 343,935 | 0.03% |
May 07, 2024 | THOROUGHBRED FINANCIAL SERVICES, LLC | reduced | -68.53 | -490,000 | 215,000 | 0.02% |
May 07, 2024 | Choate Investment Advisors | added | 4.18 | 14,639 | 1,102,540 | 0.03% |
May 07, 2024 | Avalon Trust Co | unchanged | - | -756 | 26,997 | -% |
May 07, 2024 | M&T Bank Corp | reduced | -6.38 | -305,014 | 3,105,690 | 0.01% |
May 07, 2024 | TimesSquare Capital Management, LLC | reduced | -5.18 | -6,822,000 | 81,108,000 | 1.18% |
May 07, 2024 | NorthRock Partners, LLC | added | 14.57 | 29,220 | 284,543 | 0.02% |
May 07, 2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | reduced | -34.64 | -11,083,400 | 19,352,200 | -% |
May 07, 2024 | Malaga Cove Capital, LLC | unchanged | - | -14,031 | 501,055 | 0.20% |
May 07, 2024 | Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | reduced | -0.72 | -7,894 | 222,452 | 0.01% |
Unveiling IDEXX Laboratories Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to IDEXX Laboratories Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DHR | 184.8B | 23.7B | 41.98 | 7.79 | ||||
A | 41.9B | 6.7B | 33.87 | 6.22 | ||||
IDXX | 40.2B | 3.7B | 46.43 | 10.8 | ||||
DGX | 15.1B | 9.3B | 17.88 | 1.63 | ||||
CRL | 12.1B | 4.1B | 25.45 | 2.93 | ||||
MEDP | 12.0B | 2.0B | 38.39 | 6.11 | ||||
NTRA | 11.5B | 1.1B | -26.55 | 10.66 | ||||
EXAS | 11.0B | 2.5B | -45.65 | 4.33 | ||||
MID-CAP | ||||||||
NEOG | 2.6B | 929.2M | 1.7K | 2.81 | ||||
GH | 2.3B | 563.9M | -4.73 | 4.03 | ||||
SMALL-CAP | ||||||||
CDNA | 527.1M | 280.3M | -2.77 | 1.88 | ||||
ACRS | 86.9M | 31.1M | -1.13 | 2.79 | ||||
APDN | 63.3M | 9.0M | -8.76 | 7.04 | ||||
AWH | 36.8M | 9.2M | -2.2 | 4.02 | ||||
BIOC | 183.8K | 25.9M | -0.01 | 0.01 |
IDEXX Laboratories Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 6.9% | 964 | 902 | 916 | 944 | 900 | 829 | 842 | 861 | 837 | 801 | 810 | 826 | 778 | 721 | 722 | 638 | 626 | 605 | 605 | 620 | 576 |
Cost Of Revenue | -1.2% | 371 | 375 | 368 | 371 | 357 | 344 | 335 | 347 | 338 | 345 | 338 | 337 | 307 | - | - | - | - | - | - | - | - |
Gross Profit | 12.7% | 593 | 526 | 548 | 573 | 543 | 485 | 507 | 514 | 499 | 456 | 473 | 489 | 471 | 410 | 423 | 379 | 360 | 331 | 345 | 358 | 332 |
S&GA Expenses | 5.2% | 149 | 142 | 136 | 141 | 148 | 132 | 130 | 130 | 132 | 128 | 124 | 119 | 115 | 116 | 108 | 94.00 | 116 | 106 | 105 | 101 | 107 |
R&D Expenses | 1.6% | 53.00 | 52.00 | 48.00 | 47.00 | 45.00 | 43.00 | 48.00 | 123 | 40.00 | 45.00 | 40.00 | 38.00 | 38.00 | 39.00 | 38.00 | 32.00 | 33.00 | 35.00 | 34.00 | 32.00 | 32.00 |
EBITDA Margin | 0.2% | 0.33* | 0.33* | 0.33* | 0.33* | 0.30* | 0.30* | 0.29* | 0.29* | 0.32* | 0.32* | 0.33* | 0.32* | - | - | - | - | - | - | - | - | - |
Interest Expenses | -14.6% | 8.00 | 9.00 | 9.00 | 11.00 | 13.00 | 14.00 | 11.00 | 8.00 | 7.00 | 7.00 | 7.00 | 8.00 | 8.00 | 8.00 | 8.00 | 9.00 | 8.00 | 7.00 | 7.00 | 8.00 | 8.00 |
Income Taxes | 32.7% | 60.00 | 45.00 | 56.00 | 62.00 | 54.00 | 41.00 | 53.00 | 39.00 | 48.00 | 29.00 | 44.00 | 49.00 | 36.00 | 2.00 | 18.00 | 35.00 | 25.00 | 18.00 | 24.00 | 30.00 | 22.00 |
Earnings Before Taxes | 23.3% | 295 | 240 | 268 | 286 | 268 | 213 | 234 | 171 | 241 | 192 | 219 | 252 | 240 | 177 | 164 | 184 | 137 | 109 | 133 | 156 | 125 |
EBT Margin | 0.9% | 0.29* | 0.29* | 0.29* | 0.28* | 0.26* | 0.26* | 0.25* | 0.25* | 0.28* | 0.28* | 0.28* | 0.27* | - | - | - | - | - | - | - | - | - |
Net Income | 21.1% | 236 | 195 | 212 | 224 | 214 | 172 | 181 | 132 | 194 | 163 | 175 | 203 | 204 | 175 | 146 | 149 | 112 | 90.00 | 109 | 126 | 103 |
Net Income Margin | 0.8% | 0.23* | 0.23* | 0.23* | 0.23* | 0.20* | 0.20* | 0.20* | 0.20* | 0.22* | 0.23* | 0.24* | 0.24* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -22.5% | 168 | 217 | 238 | 173 | 144 | 124 | 151 | 36.00 | 83.00 | 178 | 142 | 211 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 2.9% | 3,354 | 3,260 | 3,086 | 2,871 | 2,808 | 2,747 | 2,640 | 2,607 | 2,593 | 2,437 | 2,386 | 2,412 | 2,327 | 2,295 | 2,047 | 1,961 | 1,886 | 1,832 | 1,751 | 1,724 | 1,681 |
Current Assets | 0.4% | 1,502 | 1,495 | 1,384 | 1,179 | 1,149 | 1,101 | 1,059 | 1,043 | 1,090 | 956 | 938 | 1,001 | 1,098 | 1,063 | 869 | 780 | 721 | 680 | 703 | 712 | 698 |
Cash Equivalents | -12.4% | 397 | 454 | 332 | 133 | 111 | 113 | 99.00 | 114 | 205 | 144 | 145 | 232 | 351 | 384 | 176 | 105 | 81.00 | 90.00 | 104 | 111 | 117 |
Inventory | 2.7% | 391 | 380 | 394 | 395 | 391 | 368 | 355 | 333 | 302 | 269 | 258 | 241 | 226 | 210 | 218 | 229 | 212 | 195 | 205 | 197 | 189 |
Net PPE | 0.9% | 709 | 702 | 687 | 683 | 665 | 649 | 612 | 594 | 593 | 588 | 573 | 550 | 544 | 555 | 548 | 551 | 546 | 534 | 497 | 470 | 449 |
Goodwill | 11.7% | 409 | 366 | 362 | 364 | 363 | 362 | 355 | 356 | 361 | 359 | 4.00 | 109 | 243 | 243 | 238 | 235 | 23.00 | 240 | 25.00 | 215 | 215 |
Liabilities | 0.5% | 1,785 | 1,775 | 1,789 | 1,777 | 1,967 | 2,138 | 2,164 | 2,150 | 1,953 | 1,747 | 1,630 | 1,664 | 1,624 | 1,662 | 1,606 | 1,687 | 1,778 | 1,655 | 1,549 | 1,553 | 1,629 |
Current Liabilities | 0.6% | 957 | 952 | 970 | 884 | 1,066 | 1,236 | 1,190 | 1,167 | 971 | 764 | 634 | 652 | 621 | 583 | 527 | 541 | 846 | 725 | 627 | 619 | 690 |
Long Term Debt | -0.3% | 621 | 623 | 619 | 697 | 696 | 694 | 761 | 768 | 773 | 775 | 778 | 780 | 779 | 858 | 853 | - | - | 699 | - | - | - |
LT Debt, Current | 0.0% | 75.00 | 75.00 | 150 | 75.00 | 75.00 | 75.00 | - | - | - | 75.00 | 75.00 | 125 | 125 | 50.00 | 50.00 | - | - | - | - | - | - |
LT Debt, Non Current | -100.0% | - | 623 | 619 | 697 | 696 | 694 | 761 | 768 | 773 | 775 | 778 | 780 | 779 | 858 | 853 | - | - | 699 | - | - | - |
Shareholder's Equity | 5.7% | 1,569 | 1,485 | 1,297 | 1,094 | 841 | 609 | 476 | 457 | 640 | 690 | 755 | 748 | 703 | 633 | 441 | 273 | 108 | 178 | 203 | 172 | 52.00 |
Retained Earnings | 5.3% | 4,680 | 4,445 | 4,250 | 4,038 | 3,814 | 3,600 | 3,427 | 3,246 | 3,114 | 2,920 | 2,758 | 2,582 | 2,380 | 2,176 | 2,001 | 1,855 | 1,706 | 1,596 | 1,505 | 1,396 | 1,271 |
Additional Paid-In Capital | 2.2% | 1,605 | 1,570 | 1,543 | 1,515 | 1,490 | 1,463 | 1,438 | 1,420 | 1,400 | 1,377 | 1,359 | 1,339 | 1,321 | 1,295 | 1,274 | 1,247 | 1,230 | 1,214 | 1,190 | 1,171 | 1,156 |
Shares Outstanding | -0.2% | 83.00 | 83.00 | 83.00 | 83.00 | 83.00 | 83.00 | 84.00 | 84.00 | 84.00 | 85.00 | 85.00 | 85.00 | - | - | - | - | - | - | - | - | - |
Minority Interest | - | - | - | - | - | - | - | - | - | - | - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Float | - | - | - | - | 41,325 | - | - | - | 28,964 | - | - | - | 53,418 | - | - | - | 27,736 | - | - | - | 23,369 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -20.5% | 198,585 | 249,851 | 272,433 | 200,314 | 183,912 | 173,428 | 189,000 | 65,850 | 114,706 | 209,964 | 187,205 | 233,955 | 124,422 | 218,934 | 193,116 | 208,142 | 27,871 | 155,413 | 132,265 | 137,102 | 34,378 |
Share Based Compensation | -5.4% | 14,400 | 15,223 | 15,224 | 15,362 | 13,930 | 13,279 | 12,948 | 12,370 | 11,173 | 9,713 | 9,530 | 9,637 | 8,875 | 7,943 | 7,927 | 7,797 | 7,284 | 16,655 | 9,391 | 6,898 | 6,334 |
Cashflow From Investing | -251.4% | -106,944 | -30,435 | -27,838 | -27,470 | -39,511 | -49,229 | -49,197 | -55,086 | -41,838 | -44,040 | -49,677 | -174,663 | -24,587 | -15,690 | -19,460 | -24,556 | -49,670 | -95,911 | -37,326 | -34,085 | -38,206 |
Cashflow From Financing | -41.5% | -144,074 | -101,844 | -43,038 | -151,033 | -146,081 | -116,720 | -148,829 | -91,907 | -13,480 | -165,820 | -221,726 | -180,217 | -129,651 | 398 | -104,184 | -161,531 | 16,901 | -74,389 | -99,751 | -109,488 | -2,781 |
Buy Backs | 320.0% | 154,764 | 36,850 | 35,070 | - | - | 74,020 | 172,631 | 306,765 | 266,295 | 244,756 | 181,234 | 188,525 | 132,262 | - | - | - | 182,815 | 140,689 | 85,975 | 20,692 | 54,302 |
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenue: | ||
Total revenue | $ 964,095 | $ 900,195 |
Cost of Revenue: | ||
Total cost of revenue | 371,025 | 357,224 |
Gross profit | 593,070 | 542,971 |
Expenses: | ||
Sales and marketing | 149,453 | 147,804 |
General and administrative | 92,024 | 70,101 |
Research and development | 52,635 | 44,667 |
Income from operations | 298,958 | 280,399 |
Interest expense | (7,911) | (13,127) |
Interest income | 4,432 | 416 |
Income before provision for income taxes | 295,479 | 267,688 |
Provision for income taxes | 59,900 | 53,634 |
Net income | $ 235,579 | $ 214,054 |
Earnings per Share: | ||
Basic (in USD per share) | $ 2.84 | $ 2.58 |
Diluted (in USD per share) | $ 2.81 | $ 2.55 |
Weighted Average Shares Outstanding: | ||
Basic (in shares) | 83,096 | 82,992 |
Diluted (in shares) | 83,957 | 83,959 |
Product revenue | ||
Revenue: | ||
Total revenue | $ 543,049 | $ 505,942 |
Cost of Revenue: | ||
Total cost of revenue | 176,770 | 173,610 |
Service revenue | ||
Revenue: | ||
Total revenue | 421,046 | 394,253 |
Cost of Revenue: | ||
Total cost of revenue | $ 194,255 | $ 183,614 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current Assets: | ||
Cash and cash equivalents | $ 397,433 | $ 453,932 |
Accounts receivable, net | 507,208 | 457,445 |
Inventories | 390,599 | 380,282 |
Other current assets | 206,733 | 203,595 |
Total current assets | 1,501,973 | 1,495,254 |
Long-Term Assets: | ||
Property and equipment, net | 708,725 | 702,177 |
Operating lease right-of-use assets | 119,886 | 115,499 |
Goodwill | 408,672 | 365,961 |
Intangible assets, net | 115,352 | 84,500 |
Other long-term assets | 498,907 | 496,534 |
Total long-term assets | 1,851,542 | 1,764,671 |
TOTAL ASSETS | 3,353,515 | 3,259,925 |
Current Liabilities: | ||
Accounts payable | 117,462 | 110,643 |
Accrued liabilities | 476,249 | 478,712 |
Credit facility | 250,000 | 250,000 |
Current portion of long-term debt | 74,998 | 74,997 |
Current portion of deferred revenue | 38,193 | 37,195 |
Total current liabilities | 956,902 | 951,547 |
Long-Term Liabilities: | ||
Deferred income tax liabilities | 8,746 | 7,235 |
Long-term debt, net of current portion | 620,778 | 622,883 |
Long-term deferred revenue, net of current portion | 28,043 | 28,533 |
Long-term operating lease liabilities, net of current portion | 103,879 | 99,671 |
Other long-term liabilities | 66,261 | 65,526 |
Total long-term liabilities | 827,707 | 823,848 |
Total liabilities | 1,784,609 | 1,775,395 |
Commitments, Contingencies and Guarantees (Note 16) | ||
Stockholders’ Equity: | ||
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 107,667 shares in 2024 and 107,506 shares in 2023; Outstanding: 82,873 shares in 2024 and 83,032 shares in 2023 | 10,767 | 10,751 |
Additional paid-in capital | 1,604,749 | 1,569,565 |
Deferred stock units: Outstanding: 59 units in 2024 and 59 units in 2023 | 5,510 | 5,530 |
Retained earnings | 4,680,150 | 4,444,571 |
Accumulated other comprehensive loss | (80,397) | (71,206) |
Treasury stock, at cost: 24,794 shares in 2024 and 24,474 shares in 2023 | (4,651,873) | (4,474,681) |
Total stockholders’ equity | 1,568,906 | 1,484,530 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 3,353,515 | $ 3,259,925 |